Danese, Silvio http://orcid.org/0000-0001-7341-1351
Sands, Bruce http://orcid.org/0000-0001-5762-5042
Ng, Siew C. http://orcid.org/0000-0002-6850-4454
Peyrin-Biroulet, Laurent http://orcid.org/0000-0003-2536-6618
Article History
First Online: 1 June 2020
Competing interests
: S.D. has served as a speaker, consultant and an advisory board member for Abbvie, Ferring, Hospira, Johnson & Johnson, Merck, Millennium Takeda, Mundipharma, Pfizer, Tigenix, UCB Pharma and Vifor. B.S. has received financial support for research: Janssen, Takeda; consultancy: 4D Pharma, Abbvie, Allergan, Amgen, Arena Pharmaceuticals, Boehringer-Ingelheim, Capella Bioscience, Celgene, Celltrion Healthcare Co. Ltd., Ferring, Janssen, Lilly, Otsuka, Palatin Technologies, Pfizer, Progenity, Protagonist Therapeutics, Rheos Medicines, Salix Pharmaceuticals, Seres Therapeutics, Sienna Biopharmaceuticals, Takeda, Target PharmaSolutions, Therevance Biopharma R&D and Vivelix Pharmaceuticals. S.C.N. has served as speaker for Janssen, Abbvie, Tillotts, Takeda, Olympus, Ferring. L.P.-B. has received consulting fees: Merck, AbbVie, Janssen, Genentech, Mitsubishi, Ferring, Norgine, Tillotts, Vifor, Therakos, Pharmacosmos, Pilège, BMS, UCB Pharma, Hospira, Celltrion, Takeda, Biogaran, Boerhinger Ingelheim, Lilly, Pfizer, HAC-Pharma, Index Pharmaceuticals, Amgen and Sandoz; lecture fees: Merck, AbbVie, Takeda, Janssen, Takeda, Ferring, Norgine, Tillots, Vifor, Therakos, Mitsubishi and HAC-Pharma.
Free to read: This content has been made available to all.